Biogen Snaps Up $5.6 Billion Deal. Why Shares Fell. - Investor's Business Daily
Source:Investor's Business Daily
The buyout includes two approved drugs, but one has faced some challenges in the past.
The buyout includes two approved drugs, but one has faced some challenges in the past.